JSW
RMD icon

Journey Strategic Wealth’s ResMed RMD Stock Holding History

Journey Strategic Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Buy
950
+116
+14% +$28.9K 0.01% 737
2025
Q4 		$201K Buy
834
+80
+11% +$20.5K 0.01% 725
2025
Q3 		$206K Buy
+754
New +$206K 0.01% 661

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Journey Strategic Wealth's RMD Position: Q1 2026 in Review

Journey Strategic Wealth increased its ResMed (RMD) stake by 14% in Q1 2026, buying an estimated $28.9K and bringing the position to 950 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #737.

Journey Strategic Wealth first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Journey Strategic Wealth held 950 shares of ResMed worth $213K as of Q1 2026.
  • Journey Strategic Wealth bought 116 ResMed shares in Q1 2026, an estimated $28.9K.
  • ResMed made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #737 holding.
  • Journey Strategic Wealth first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.